Results 151 to 160 of about 22,481 (247)

Biovigilance in Faecal Microbiota Transplantation: 7‐Year Cohort Study and Framework for Microbiological Assessments of Infectious Adverse Events

United European Gastroenterology Journal, Volume 14, Issue 5, June 2026.
ABSTRACT Background and Aims Faecal microbiota transplantation (FMT) is increasingly used. However, no systematic approach exists to assess infectious risks after FMT, leading to underreporting. We evaluated infectious complications at the Netherlands Donor Feces Bank (NDFB) and proposed a structured biovigilance approach aligned with the EU Regulation
V. O. Chernova, J. van Prehn, B. Groenewegen, E. van Lingen, E. J. Kuijper, M. M. C. Lambregts, E. van Nood, G. Choi, M. D. Hazenberg, J. J. Keller, E. M. Terveer   +10 more
wiley   +1 more source

Environmental Preferences and Functional Variations of Methanotrophs in Northeast Qinghai‐Tibet Plateau Wetlands

Environmental Microbiology Reports, Volume 18, Issue 3, June 2026.
Significant environmental preference between type I and type II methanotrophs is regulated by soil ion concentration (pH and electrical conductivity) in wetlands. Type II methanotrophs (Methylocystis, etc.) contributes more to soil methane oxidation than type I methanotrophs.
Kun He, Jiacheng Zhao, Jianbin Pan, Qi Zhang, Sizhong Yang, Huyuan Feng   +5 more
wiley   +1 more source

Association Between Osimertinib Dose Reduction and Treatment Outcomes in First‐Line EGFR‐Mutated Advanced NSCLC: The Impact of Post‐Progression Management

Thoracic Cancer, Volume 17, Issue 12, June 2026.
In first‐line EGFR‐mutated advanced NSCLC, osimertinib dose reduction was not associated with worse overall survival. Appropriate dose modification may preserve patient fitness and improve access to subsequent therapy, highlighting the importance of post‐progression management.
Issei Oi, Kohei Fujita, Takuma Imakita, Mitsuhiro Tukino, Tetsuo Noguchi, Yuta Okada, Saiki Yoshimura, Naoki Fujimoto, Shogo Toyama, Atsuko Watanabe, Takanori Ito, Ryosuke Kaku, Osamu Kanai, Masatsugu Ohuchi, Kiminobu Tanizawa, Satoru Sawai, Tadashi Mio   +16 more
wiley   +1 more source

Bispecific Ligand‐Based EphB4 CAR‐T Cells Generated Using Ephrin‐B2 Show Potent Antitumor Activity Against Lung Adenocarcinoma

Cancer Science, Volume 117, Issue 6, Page 1724-1735, June 2026.
EphB4 and EphA2 positivity in lung adenocarcinoma samples was high. Ligand‐based EphB4 CAR‐T cells exhibit bispecificity, targeting both EphB4 and EphA2. EphB4 CAR‐T cells exert significant antitumor effects against lung adenocarcinoma. ABSTRACT Chimeric antigen receptor (CAR)‐T cells generated using ephrin‐B2, the natural ligand for ephrin type‐B ...
Hirotaka Kumeda, Koichi Hirabayashi, Shuji Mishima, Kotaro Morita, Yu Furui, Marina Fujioka, Tomoyuki Nakajima, Miyuki Tanaka, Yoshinori Sato, Takeshi Uehara, Shigeki Yagyu, Kimihiro Shimizu, Yozo Nakazawa   +12 more
wiley   +1 more source

Expression of cholera toxin B subunit in Saccharomyces cerevisiae [PDF]

Cholera toxin, secreted by Vibrio cholerae, consists of A and B subunits. Cholera toxin B subunit (CTB) is used in many scientific research. It has already been expressed in several bacterial and plant systems.
ارزنلو, محسن, آهنگرزاده رضایی, محمد, زواران حسینی, احمد, توچیکوبو, کونیو, شاهرخی, نادر, یاسودا, یوکو, رضایی, عباس   +6 more
core  

EnterohemorrhagicEscherichia coliinfection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells

, 2011
Gastrointestinal infection with Shiga toxins producing enterohemorrhagic Escherichia coli causes the spectrum of gastrointestinal and systemic complications, including hemorrhagic colitis and hemolytic uremic syndrome, which is fatal in ∼10% of patients.
Ann Hubbard, Edgar Boedeker, Valeriy Lukyanenko, Liudmila Cebotaru, Irina Malyukova, Michael Delannoy, Olga Kovbasnjuk, Chengru Zhu   +7 more
core   +1 more source

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 521-530, June 2026.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets   +2 more
wiley   +1 more source

Prevalence of Virulence Genes of Escherichia Coli O157:H7 Isolated from Patients with Urinary Tract Infections in Shiraz, Iran

Medical Laboratory Journal, 2015
Background and Objective: Escherichia coli O157:H7 is one of the most well-known pathogenic bacteria worldwide that can develop severe diseases such as hemolytic uremic syndrome (HUS).
Kargar, M, Kargar, M, Zareian Jahromi, M
doaj  

Inhibitory effect of tyrphostin 47 on Shiga toxin-induced cell death [PDF]

, 2006
The inhibitory effects of tyrosine kinase inhibitors including tyrphostin 25, 47 and 51 on Shiga toxin 1-induced cell death and p38 mitogen-activated protein kinase （p38 MAPK） phosphorylation were examined in Vero cells.
60281218, Horie, Atsuko, 5451, 60608272, Gunji, Yasuhiro, イケダ, マサヒロ, イトウ, カツアキ, 1071, 1081, 園田, 紘子, 池田, 正浩, Ito, Katsuaki, ソノダ, ヒロコ, Shimono, Mariko, 伊藤, 勝昭, Oshikawa, Sayaka, Sonoda, Hiroko, Yamasaki, Shinji, Ikeda, Masahiro   +18 more
core  

Transmission and quantification of verocytotoxin-producing Escherichia coli O157 in dairy cattle and calves

, 2009
Data from a field study of 14 months duration in a naturally colonized dairy herd and data from an experiment with calves were used to quantify transmission of verocytotoxin-producing Escherichia coli (VTEC O157) in cattle.
Schouten, J.M., Graat, E.A.M., Jong, M.C.M., de, Frankena, K., Zijderveld, F.G., van   +4 more
core   +1 more source